VR Adviser’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,318,327
Closed -$7.65M 39
2023
Q4
$7.65M Sell
1,318,327
-1,425,798
-52% -$10.1M 0.52% 30
2023
Q3
$27.6M Sell
2,744,125
-773,000
-22% -$8.93M 2.9% 12
2023
Q2
$41.7M Hold
3,517,125
6.67% 6
2023
Q1
$28.1M Hold
3,517,125
5.49% 7
2022
Q4
$34.2M Buy
3,517,125
+183,971
+6% +$1.99M 5.76% 6
2022
Q3
$38.7M Buy
3,333,154
+147,581
+5% +$1.86M 5.98% 6
2022
Q2
$31.8M Buy
3,185,573
+1,134,513
+55% +$14.7M 6.26% 6
2022
Q1
$37.5M Buy
2,051,060
+29,075
+1% +$513K 6.08% 5
2021
Q4
$47.2M Buy
2,021,985
+379,689
+23% +$8.34M 6.45% 5
2021
Q3
$36.2M Buy
1,642,296
+366,465
+29% +$7.46M 4.65% 10
2021
Q2
$27.7M Buy
+1,275,831
New +$26.1M 3.36% 11

Other funds holding GHRS

VR Adviser's GHRS Position: Q1 2024 in Review

VR Adviser sold out of GH Research (GHRS) in Q1 2024, closing a stake of 1,318,327 shares — an estimated $7.65M sold.

VR Adviser first reported a position in GHRS in Q2 2021 and held it in 11 quarters. The position peaked at $47.2M in Q4 2021. 32 funds tracked by Wall St. Rank hold GHRS as of Q1 2024.

  • VR Adviser reported no remaining GH Research position as of Q1 2024 after selling out during the quarter.
  • VR Adviser sold 1,318,327 GH Research shares in Q1 2024, an estimated $7.65M.
  • VR Adviser first reported a position in GH Research in Q2 2021 and held it in 11 quarters.
  • VR Adviser's GH Research position peaked at $47.2M in Q4 2021.
  • 32 funds tracked by Wall St. Rank held GH Research as of Q1 2024.

Based on VR Adviser's 13F filing for Q1 2024, filed 15 May 2024.